Gemina Laboratories Ltd. (CSE: GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.550
-0.080 (-12.70%)
Jan 20, 2025, 4:00 PM EST
-1.79%
Market Cap 41.02M
Revenue (ttm) n/a
Net Income (ttm) -3.72M
Shares Out 74.57M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,500
Average Volume 5,940
Open 0.600
Previous Close 0.630
Day's Range 0.550 - 0.600
52-Week Range 0.280 - 0.920
Beta 1.01
RSI 40.84
Earnings Date May 30, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.